A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 15, 2016

Primary Completion Date

May 23, 2017

Study Completion Date

May 23, 2017

Conditions

Travelers' Diarrhea

Interventions

DRUG

Rifaximin (Sandoz GmbH) tablet

200 mg tablet administered orally.

DRUG

Rifaximin (Xifaxan)

200 mg tablet administered orally

DRUG

Placebo

Matching Placebo tablet administered orally

Trial Locations (1)

Sandoz Investigative Site, Mexico City